Tag: Hatch-Waxman
180-Day Exclusivity and Authorized Generics: Legal Pitfalls and Market Impact
The 180-day exclusivity rule was meant to reward generic drug makers for challenging patents-but authorized generics let brand-name companies undercut them. Here’s how the law works, why it’s failing, and what’s being done to fix it.